Investigator initiated clinical trials (IICT)

Instrument/Program eligible areas: 
SWITZERLAND
Topic/s: 

The special programme for Investigator Initiated Clinical Trials (IICTs) of the Swiss National Science Foundation (SNSF) supports clinical trials as defined in the Federal Act on Research involving Human Beings (Human Research Act, HRA)* and regulated by the Ordinance on Clinical Trials in Human Research (Clinical Trials Ordinance, ClinO)**. These trials address a documented unmet medical need and are of value to the patients but not in industry focus.

Excluded from support through IICT programme are:

Non-randomized and uncontrolled studies

Pilot studies, proof of concept studies

Animal studies, preclinical studies

Studies with safety endpoints only

Observational studies

Physiological, pathophysiological studies and technology developments without prospective allocation to a health-related intervention

Studies involving healthy subjects

Studies conducted for direct commercial purposes

* Clinical trial means a research project in which persons are prospectively assigned to a health-related intervention** in order to investigate its effects on health or on the structure and function of the human body.

Field: 
Research
Innovation
Deadline date: 
1st Jul 2019
1st Nov 2019
Call typology: 
Call